Tuesday, December 09, 2025 | 06:35 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Chennai Covishield volunteer to move court against Serum Institute

Serum Institute of India said the volunteer was "falsely laying the blame for his medical problems on the vaccine trial"

Serum institute, coronavirus, vaccine, pharma, drugs
premium

SII produces 1.5 billion annual dosages for polio, diphtheria, tetanus, BCG among other vaccines

T E Narasimhan Chennai
The 40-year-old Chennai volunteer, who had earlier sent a legal notice to the Pune-based Serum Institute of India (SII) against its Covishield vaccine trial, has decided to move court.

Earlier, he had sent a legal notice seeking ~5 crore in damages, alleging he had developed severe neurological complications and impaired cognitive functions after he took the first jab, for which SII is seeking marketing authorisation from the Indian regulator.

R Rajaram, one of the advocates for the volunteer's family, told Business Standard that they are preparing the writ petition and will be moving court in the next few